FDA Accepts Genta's NDA Amendment as Complete Response for ... PR Newswire (press release), NY - Patients with CLL typically develop symptoms that may progress over a period of years, ultimately producing a generalized depression of immunity, ... |
Tuesday, July 15, 2008
FDA Accepts Genta's NDA Amendment as Complete Response for ... - PR Newswire (press release)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment